Propiedad y actividad de insiders de Molecular Partners AG (MOLN): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.92 |
| Capitalización | $147M |
| Bolsa | NASDAQ |
| País | CH |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $149.7M | $131.3M | $99.0M | $75.7M | $133.7M | $71.8M | $87.9M | $67.3M | $63.9M | $82.7M |
| Inversiones a Corto | $30.5M | $9.7M | 0 | $19.4M | $40.0M | $61.0M | $161.2M | $119.6M | $85.6M | $10.4M |
| Cuentas por Cobrar | $844000 | $1.2M | $51.6M | $2.5M | $2.8M | $25.7M | $1.7M | $3.1M | $286000 | $1.9M |
| Inventario | 0 | -$9.4M | -$2.3M | -$486000 | -$199000 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $181.6M | $142.5M | $153.3M | $99.9M | $177.8M | $164.2M | $254.8M | $192.5M | $154.3M | $96.9M |
| Inmovilizado Material | $2.5M | $1.9M | $1.5M | $4.2M | $9.4M | $8.1M | $7.2M | $5.7M | $4.2M | $5.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $47000 | $27000 | $382000 | $772000 | $347000 | $330000 | $271000 | $212000 | $49000 | $2000 |
| Activos Totales | $184.1M | $144.4M | $155.2M | $104.9M | $187.5M | $172.7M | $262.3M | $198.4M | $158.5M | $102.1M |
| Cuentas por Pagar | $1.0M | $716000 | $2.1M | $2.0M | $2.8M | $4.9M | $997000 | $410000 | $679000 | $937000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $15.8M | $14.1M | $36.9M | $28.6M | $57.7M | $46.9M | $17.3M | $14.4M | $10.8M | $11.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $48.3M | $27.7M | $63.5M | $50.8M | $80.3M | $65.4M | $27.1M | $21.9M | $16.9M | $21.8M |
| Reservas | -$37.3M | -$60.7M | -$89.9M | -$130.9M | -$195.2M | -$250.9M | -$127.8M | -$191.8M | -$246.3M | -$311.8M |
| Patrimonio Neto | $135.8M | $116.7M | $91.7M | $54.1M | $107.2M | $107.3M | $235.2M | $176.4M | $141.6M | $80.3M |
| Deuda Total | 0 | 0 | 0 | $2.5M | $7.2M | $6.0M | $4.8M | $3.7M | $2.4M | $3.6M |
| Deuda Neta | -$180.2M | -$141.1M | -$99.0M | -$92.5M | -$166.5M | -$126.8M | -$244.3M | -$183.2M | -$147.0M | -$89.4M |
| Capital Circulante | $165.8M | $128.4M | $116.5M | $71.3M | $120.1M | $117.3M | $237.5M | $178.0M | $143.5M | $85.8M |
Salud financiera
| Deuda / Patrimonio | 0.05 |
| Ratio corriente | 7.27 |
Rentabilidad
| Rentabilidad sobre capital | -67.67% |
| Rentabilidad sobre capital invertido | -76.91% |
| Rentabilidad sobre activos | -67.68% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ALEC · APLT · CRBP · CRDF · ELTX · MIST · NKTX
Explorar sector: Healthcare · Biotechnology
Más secciones de MOLN: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones